SpecialtyCare Acquires Trident Health Resources, Inc.
- Increases national coverage and scope of services, extending market leadership as the largest, most comprehensive provider of patient-centered perfusion services
- Grows SCOPE™ database to advance demonstrated expertise in clinical research that is defining industry standards and clinical benchmarks
- Expands the audience that benefits from SpecialtyCare’s transparent quality reporting and ability to help maintain regulatory compliance and avoid penalties
Nashville, TN – February 1, 2017 – SpecialtyCare, a leading provider of outsourced perfusion, intraoperative neuromonitoring, and surgical services, announced today that it has completed an asset purchase of Trident Health Resources, Inc., a highly regarded, clinically focused perfusion services company. With deeper and expanded coverage in 44 states, SpecialtyCare’s perfusion division now supports over 120,000 annual open heart and perfusion-related procedures for 850 surgeons at more than 350 hospitals, extending the company’s market leading position as the largest and most comprehensive provider of cardiovascular perfusion and perfusion-related services in the U.S.
SpecialtyCare CEO Melvin F. Hall, PhD, said, “I am thrilled to welcome the people of Trident to our team. They have built a tremendous reputation for the highest level of perfusion expertise based on a patient-first philosophy and an evidence-based approach to care. That powerful combination makes Trident an extremely valuable clinical partner.”
Trident is also known for its ethical business practices and regulatory compliance, which align with SpecialtyCare’s focus on safeguarding customers and patients from healthcare fraud, waste, and abuse. With this acquisition, SpecialtyCare continues to demonstrate its commitment to limiting customer exposure to the financial risk and reputation damage that can result from illegal physician referrals, kickbacks, and other activities that are under increasing government scrutiny.
According to Trident CEO and President Ralph E. Jordan, who founded the company in 1988, “After growing this business from the ground up and taking great care to build a reputation for excellence and integrity, it was essential for me to choose a partner who would honor and sustain that legacy. I have complete confidence that SpecialtyCare is the right choice. Our clinicians will enjoy new professional development opportunities with a strong and stable company while also using SpecialtyCare’s robust benchmarking and evidenced-based clinical standards to continually improve patient care.”
Samuel Weinstein, MD, MBA, SpecialtyCare’s President and Chief Medical Officer, said, “We’re excited about Trident’s significant clinical expertise and legacy of data collection. Combining our resources will enhance the research value and best practices that are derived from SCOPE™, the SpecialtyCare Operative Procedural Registry, which is the largest perfusion procedure database of its kind and continues to grow with the 100,000+ open heart and perfusion procedures we participate in each year. Our customers will benefit from richer comparative analyses that detail opportunities for improvement in clinical performance, operational cost and efficiency, and patient outcomes—metrics vital to success in a value-based healthcare environment.”
More than 13,500 physicians at 1,300 hospitals trust SpecialtyCare to help them achieve exceptional care outcomes, regulatory compliance, and financial results. With approximately 1,700 associates supporting over 375,000 procedures annually, we maintain SCOPE™, the SpecialtyCare Operative Procedural Registry, which is used to define standards, determine benchmarks, disseminate best practices, and foster innovations that improve patient outcomes, increase efficiencies, and minimize costs. We are accredited and certified by The Joint Commission. By developing expertise beyond industry requirements, our customers can be certain they have the best partner for clinical excellence in perfusion, intraoperative neuromonitoring, autotransfusion, sterile processing management, surgical assist, and minimally invasive surgical support.
Senior Vice President, Marketing